GlassScriptPhysician profile
Tracy M Giese
NPI 1124492608
$5,974.45
in general payments reported to CMS, 2019-2025
38 companies · $724 in 2025
The $724 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,018 · 2022: $1,677 · 2023: $1,569 · 2024: $986 · 2025: $724.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,237 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,236.53 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $934.77 | 2022-2025 | Korlym |
| Novo Nordisk INC | $872.74 | 2021-2025 | Ozempic, Rybelsus |
| Dexcom, INC. | $653.36 | 2021-2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $325.84 | 2021-2024 | Farxiga, Fasenra |
| Mannkind Corporation | $285.07 | 2022-2025 | Afrezza |
| Lilly USA, LLC | $239.68 | 2022-2023 | Jardiance, Mounjaro, Humulin |
| Tandem Diabetes Care, INC. | $218.11 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Zealand Pharma US, INC. | $217.50 | 2021 | |
| Medtronic, INC. | $206.92 | 2021-2025 | Minimed 780g |
| Abbott Laboratories | $203.00 | 2022-2025 | Freestyle Libre 3 |
| Cequr Corporation | $178.08 | 2023-2025 | Cequr Simplicity |
| Bayer Healthcare Pharmaceuticals INC. | $175.80 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $159.98 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $134.90 | 2023 | Camzyos |
| Pfizer INC. | $129.81 | 2022-2024 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $117.34 | 2022-2025 | Omnipod |
| Sanofi-Aventis U.S. LLC | $115.64 | 2021-2024 | |
| Urovant Sciences INC | $112.30 | 2022 | |
| Esperion Therapeutics, INC. | $79.20 | 2021 | |
| Xeris Pharmaceuticals, INC. | $61.98 | 2022-2024 | Gvoke Hypopen |
| Organogenesis INC. | $60.23 | 2022-2023 | Puraply |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.15 | 2022-2023 | Tradjenta, Synjardy |
| Genentech USA, INC. | $51.80 | 2024 | Xolair |
| Nevro Corp. | $50.62 | 2022-2023 | Senza |
| Alexion Pharmaceuticals, INC. | $49.88 | 2022-2023 | |
| Paratek Pharmaceuticals, INC. | $39.08 | 2022-2023 | Nuzyra |
| Antares Pharma, INC. | $31.37 | 2022-2023 | Nocdurna, Tlando, Xyosted |
| Amgen INC. | $29.26 | 2023 | Repatha, Evenity, Prolia |
| Ipsen Biopharmaceuticals, INC | $24.66 | 2022 | |
| Grifols USA, LLC | $22.75 | 2024 | Xembify |
| Smith+Nephew, INC. | $22.13 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.31 | 2024 | Takhzyro |
| Abbvie INC. | $20.02 | 2023 | |
| Melinta Therapeutics, LLC | $16.87 | 2022 | |
| Halozyme INC | $16.72 | 2023 | |
| Merck Sharp & Dohme LLC | $14.75 | 2022 | |
| Novartis Pharmaceuticals Corporation | $12.98 | 2022 | |
| Boston Scientific Corporation | $12.85 | 2023 | Watchman Access System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Giese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.